中国保健营养(中旬刊)
中國保健營養(中旬刊)
중국보건영양(중순간)
China Hwalth Care & nutrition
2013年
1期
7-8
,共2页
阿里木·帕塔尔%亚森克里木%阿迪拉阿力木%帕热扎木木塔力甫%努尔比耶艾海提%热伊拉阿布都克里木%古丽赛娜木艾合买提
阿裏木·帕塔爾%亞森剋裏木%阿迪拉阿力木%帕熱扎木木塔力甫%努爾比耶艾海提%熱伊拉阿佈都剋裏木%古麗賽娜木艾閤買提
아리목·파탑이%아삼극리목%아적랍아력목%파열찰목목탑력보%노이비야애해제%열이랍아포도극리목%고려새나목애합매제
埃杜升营养液%高脂血症动物模型%降血脂
埃杜升營養液%高脂血癥動物模型%降血脂
애두승영양액%고지혈증동물모형%강혈지
Aldos nutrient medium%Hyperlipidemia rat model%blood lipid
目的:探讨埃杜升营养液对高脂血症动物模型血脂水平的影响.方法:通过高脂血症动物模型的建立方法,将小鼠随机分为空白对照组、模型组、阳性对照组及低、中、高剂量组,每组10只.观察小鼠的血脂变化来而探讨埃杜升营养液对高脂血症大鼠模型降低血脂作用的影响.结果:血清甘油三酯(TG)含量随着埃杜升营养液剂量的增加而呈减少的趋势,其中高剂量组明显低于其它各实验组(P<0.01).血清总胆固醇(TC)含量随着埃杜升营养液剂量的增加而减少,其中高剂量组与中、低剂量、阴性对照组和正常对照组比较含量明显下降(P<0.01),而阴性对照组高于其他各组 P<0.01.高密度脂蛋白胆固醇(HDL–C)含量高剂量组高于其他各组,差异有显著性(P<0.01).低密度脂蛋白胆固醇(LDL-C)指标,埃杜升营养液高、中、低剂量组之间无显著差异(P>0.05),阳性对照组略低于埃杜升营养液各剂量组(P>0.05),阳性对照组明显低于阴性对照组(P<0.01)和正常对照组(P<0.05);阴性对照组明显高于其他各组,差异有显著性(P<0.01).结论:埃杜升营养液对高脂血症大鼠有显著的降低血清 TC、TG、LDL-C,升高 HDL-C 的作用.
目的:探討埃杜升營養液對高脂血癥動物模型血脂水平的影響.方法:通過高脂血癥動物模型的建立方法,將小鼠隨機分為空白對照組、模型組、暘性對照組及低、中、高劑量組,每組10隻.觀察小鼠的血脂變化來而探討埃杜升營養液對高脂血癥大鼠模型降低血脂作用的影響.結果:血清甘油三酯(TG)含量隨著埃杜升營養液劑量的增加而呈減少的趨勢,其中高劑量組明顯低于其它各實驗組(P<0.01).血清總膽固醇(TC)含量隨著埃杜升營養液劑量的增加而減少,其中高劑量組與中、低劑量、陰性對照組和正常對照組比較含量明顯下降(P<0.01),而陰性對照組高于其他各組 P<0.01.高密度脂蛋白膽固醇(HDL–C)含量高劑量組高于其他各組,差異有顯著性(P<0.01).低密度脂蛋白膽固醇(LDL-C)指標,埃杜升營養液高、中、低劑量組之間無顯著差異(P>0.05),暘性對照組略低于埃杜升營養液各劑量組(P>0.05),暘性對照組明顯低于陰性對照組(P<0.01)和正常對照組(P<0.05);陰性對照組明顯高于其他各組,差異有顯著性(P<0.01).結論:埃杜升營養液對高脂血癥大鼠有顯著的降低血清 TC、TG、LDL-C,升高 HDL-C 的作用.
목적:탐토애두승영양액대고지혈증동물모형혈지수평적영향.방법:통과고지혈증동물모형적건립방법,장소서수궤분위공백대조조、모형조、양성대조조급저、중、고제량조,매조10지.관찰소서적혈지변화래이탐토애두승영양액대고지혈증대서모형강저혈지작용적영향.결과:혈청감유삼지(TG)함량수착애두승영양액제량적증가이정감소적추세,기중고제량조명현저우기타각실험조(P<0.01).혈청총담고순(TC)함량수착애두승영양액제량적증가이감소,기중고제량조여중、저제량、음성대조조화정상대조조비교함량명현하강(P<0.01),이음성대조조고우기타각조 P<0.01.고밀도지단백담고순(HDL–C)함량고제량조고우기타각조,차이유현저성(P<0.01).저밀도지단백담고순(LDL-C)지표,애두승영양액고、중、저제량조지간무현저차이(P>0.05),양성대조조략저우애두승영양액각제량조(P>0.05),양성대조조명현저우음성대조조(P<0.01)화정상대조조(P<0.05);음성대조조명현고우기타각조,차이유현저성(P<0.01).결론:애두승영양액대고지혈증대서유현저적강저혈청 TC、TG、LDL-C,승고 HDL-C 적작용.
Objective:To study Aldos nutrient medium on reducing blood lipid in Hyperlipidemia-rat-model. Methods:The Hyperlipidemia model was evaluated after 2 weeks according to blood lipid level. After the Hyperlipidemia-rat-model was established successfully, one group of the model groups was used as negative control group. The subjects in negative control group were fed as usual and the rest 4 groups were fed separately. Three groups of the model were treated respectively with the dosage of 2.5ml/100g (high dose-group), 1.5 ml/100g (medium dose-group) and 0.5ml/100g (low dose- group) of Aldos nutrient medium twice a day. The other was used as positive control group and the subjects were given Simvastatin Tablets 0.265mg/100g. All the subjects of the five model groups were treated continuously for 35 days. To evaluate the establishment of the Hyperlipidemia-rat-model, the serum triglyceride(TG),total cholesterol(TC),high density lipoprotein(HDL), low density lipoprotein(LDL) were measured in the middle and at the end of the treatment respectively. Results:The serum TG and TC decreased significantly after the intake ofAldos nutrient medium in different dose groups (P<0.01).The higher the dose, the lower the serum TG and TC. It was shown that the TG and TC in serum in the normal control group were higher than all the other model groups (P<0.01); The serum HDL in high dose-group was higher than other groups(P<0.01), serum LDL in the negative control group increased significantly(P<0.01). Conclusion:The role of Aldos nutrient medium on decreasing serum TG,TC,LDL and increasing serum HDL was significant, which provided strong evidence for the future research of Aldos nutrition medium on strengthening body immune system and preventing certain diseases.